CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Anthem Massachusetts

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
B
Index (ASP = 100)
102.9
Vs. acquisition
+0.2%
Brand index
102.9
Biosimilar index
103.8
Contract variability
Low
Drugs observed
851
States
25

Contracts above the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 90% of billing volume on the single most common rate — a card system — a few standard rates, most practices on the standard one.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.